arginine and Blood Coagulation Disorders

arginine has been researched along with Blood Coagulation Disorders in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (45.16)	18.7374
1990's	8 (25.81)	18.2507
2000's	4 (12.90)	29.6817
2010's	3 (9.68)	24.3611
2020's	2 (6.45)	2.80

Authors

Authors	Studies
Banerjee, A; Bartley, M; Cohen, M; Coleman, JR; Moore, EE; Samuels, JM; Sauaia, A; Silliman, CC; Vigneshwar, N	1
Bergis, B; Chanson, N; Chassin, O; Drouot, S; Gleizes, O; Legris, N; Proulle, V; Ract, C; Walle, EM; Werner, M	1
Ansell, JE	1
Harness, HL; Johnson, CE; McKamie, WA; Schmitz, ML; St Amour, ED	1
Barash, P; Coady, M; Fareed, J; Genzen, JR; Hoppensteadt, D; Kurup, V; Wu, YY	1
Allemand, E; Berti de Marinis, G; Bonamigo, E; Girolami, A	1
Akhavan, S; De Cristofaro, R; Landolfi, R; Lavoretano, S; Mannucci, PM; Peyvandi, F	1
GLUECK, HI	1
LESTRADET, H	1
Aranki, SF; Fitzgerald, D; Gasparovic, H; Nathan, NS	1
Komaroff, AL	1
Holcenberg, JS	1
Brennan, SO; Brosstad, F; George, PM; Ridgway, H; Stormorken, H	1
Furihata, K; Ishida, F; Kitano, K; Kodaira, H; Shimodaira, S; Takamiya, O	1
Charbonnier, B; Delahousse, B; Fimbel, B; Gruel, Y; Iochmann, S; Pouplard, C	1
Griffin, JH; Petäjä, JM	1
Inoue, S; Kawata, S; Kayanoki, Y; Kiso, S; Matsuzawa, Y; Tamura, S; Taniguchi, N; Yamasaki, E	1
Brajerski, W	1
Badowski, A; Orłowski, T; Witkowski, W	1
Bruhn, HD; Gram, J; Seydewitz, HH; Witt, I	1
Biasiutti, FD; Furlan, M; Lämmle, B; Leupin, L	1
Bauer, KA; Chin, DT; Clyne, LP; Kaczmarek, E; Lee, MH; McDonagh, J; McIntosh, S; Oda, A	1
Diuguid, DL; Furie, B; Furie, BC; Rabiet, MJ	1
Hirata, H; Matsuda, M; Miyata, T; Shimonishi, Y; Takao, T; Takeda, Y; Terukina, S	1
Barbui, T; Beck, EA; Berrettini, M; Furlan, M; Henschen, A; Hilgard, P; Kaudewitz, H; Nenci, GG; Reber, P	1
Iwanaga, S; Kasamatsu, A; Matsuda, M; Miyata, T; Murakami, T; Takeda, Y; Terukina, S	1
Dreyfus, M; Guillin, MC; Huisse, MG	1
Abildgaard, U	1
Geokas, MC; Rinderknecht, H	1
Donaldson, VH; Ratnoff, OD; Saito, H	1
Szczeklik, A	1

Reviews

3 review(s) available for arginine and Blood Coagulation Disorders

Article	Year
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:3 Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K	2016
[Plasma clotting system in neoplastic diseases]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1976, Jul-05, Volume: 31, Issue:27 Topics: Animals; Arginine; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Humans; Neoplasms; Platelet Aggregation; Thrombophlebitis; Thrombosis	1976
Thrombin inhibiting action of heparin. Folia haematologica (Leipzig, Germany : 1928), 1972, Volume: 98, Issue:4 Topics: Antithrombins; Arginine; Blood Coagulation Disorders; Fibrinogen; Half-Life; Heparin; Platelet Adhesiveness; Protamines; Thrombin; Tosyl Compounds	1972

Other Studies

28 other study(ies) available for arginine and Blood Coagulation Disorders

Article	Year
Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis. Shock (Augusta, Ga.), 2020, Volume: 53, Issue:5 Topics: Adult; Aniline Compounds; Arginine; Benzhydryl Compounds; Blood Coagulation Disorders; Complement Activation; Complement Inactivating Agents; Complement Pathway, Alternative; Elapid Venoms; Female; Fibrinolysis; Humans; Male; Middle Aged; Peptides, Cyclic; Tetrahydronaphthalenes; Thrombelastography; Young Adult	2020
[Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report]. Annales de biologie clinique, 2020, Dec-01, Volume: 78, Issue:6 Topics: 4-Hydroxycoumarins; Aged; Anticoagulants; Arginine; Blood Coagulation Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Indenes; Intracranial Thrombosis; Male; Middle Aged; Neurosurgical Procedures; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Vitamin K	2020
RapidTEG observation suggests activation of factor VII may overcome argatroban-induced coagulopathy. Journal of cardiothoracic and vascular anesthesia, 2009, Volume: 23, Issue:5 Topics: Arginine; Blood Coagulation Disorders; Child; Factor VII; Female; Humans; Pipecolic Acids; Sulfonamides; Thrombelastography; Time Factors	2009
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis. Transfusion, 2010, Volume: 50, Issue:4 Topics: Aged; Arginine; Blood Coagulation Disorders; Cardiopulmonary Bypass; Child; Heart Transplantation; Heparin; Humans; Infusions, Intravenous; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Thrombosis	2010
Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua). European journal of haematology, 2011, Volume: 86, Issue:2 Topics: Animals; Arginine; Blood Coagulation Disorders; Cattle; Factor VII; Factor VII Deficiency; Female; Global Health; Glutamine; Homozygote; Humans; Male; Mutation; Placenta; Pregnancy; Rabbits	2011
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood, 2002, Aug-15, Volume: 100, Issue:4 Topics: Arginine; Blood Coagulation Disorders; Cell Line; Consanguinity; Factor Va; Factor Xa; Female; Fibrinopeptide A; Hemorrhagic Disorders; Heparin Cofactor II; Histidine; Homozygote; Humans; Hydrolysis; Infant; Mutagenesis, Site-Directed; Mutation; Protein C; Prothrombin; Receptor, PAR-1; Receptors, Thrombin; Thrombin; Thrombomodulin; Thromboplastin; Transfection	2002
The utilization of a synthetic substrate (TAMe) to measure the plasma prothrombin in coagulation disorders. The Journal of laboratory and clinical medicine, 1957, Volume: 49, Issue:1 Topics: Arginine; Blood Coagulation Disorders; Hemorrhagic Disorders; Humans; Plasma; Prothrombin; Prothrombin Time; Sulfonamides; Tosylarginine Methyl Ester	1957
[THE PHYSIOPATHOLOGY AND TREATMENT OF HEPATIC COMA]. Concours medical, 1964, Mar-07, Volume: 86 Topics: Alkalosis; Ammonia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Arginine; Bilirubin; Blood Coagulation Disorders; Blood Glucose; Cortisone; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypoglycemia; Liver; Metabolism; Tryptophan; Urea; Water-Electrolyte Balance	1964
Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. The Annals of thoracic surgery, 2004, Volume: 78, Issue:6 Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Arginine; Blood Coagulation Disorders; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis	2004
By the way, doctor. I am 92 and have poor blood circulation and an irregular heartbeat. Is it okay for me to take 500 milligrams of L-arginine a day? Harvard health letter, 2007, Volume: 33, Issue:1 Topics: Aged, 80 and over; Arginine; Arrhythmias, Cardiac; Blood Coagulation Disorders; Drug Interactions; Herpesviridae; Humans; Virus Activation	2007
Enzyme therapy: problems and solutions. Annual review of biochemistry, 1982, Volume: 51 Topics: Animals; Arginine; Blood Coagulation Disorders; Enzyme Therapy; Enzymes; Enzymes, Immobilized; Erwinia; Escherichia coli; Fabry Disease; Folic Acid; gamma-Glutamyl Hydrolase; Gaucher Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Lysosomes; Metabolic Clearance Rate; Neoplasms; Poisoning; Ribonucleases; Urokinase-Type Plasminogen Activator	1982
Characterisation of Fibrinogen Oslo IV by electrospray mass spectrometry. Thrombosis and haemostasis, 1997, Volume: 77, Issue:5 Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Codon; Fibrinogens, Abnormal; Glycine; Heterozygote; Humans; Mass Spectrometry; Point Mutation	1997
Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations. Acta haematologica, 1997, Volume: 98, Issue:1 Topics: Adult; Aged; Arginine; Blood Coagulation Disorders; China; Drug Resistance; Factor V; Female; Glutamine; Humans; Japan; Korea; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Protein C	1997
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1997, Volume: 8, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Blood Coagulation Disorders; Case-Control Studies; Child; Factor V; Factor V Deficiency; Female; Glutamine; Heterozygote; Homozygote; Humans; Male; Middle Aged; Pedigree; Point Mutation; Protein C	1997
Activated protein C resistance: What have we learned now that the dust has settled? Annals of medicine, 1997, Volume: 29, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation Disorders; Cerebrovascular Disorders; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophlebitis; Thrombosis	1997
Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation. Metabolism: clinical and experimental, 1999, Volume: 48, Issue:9 Topics: Adult; Amino Acid Metabolism, Inborn Errors; Antithrombin III; Arginine; Blood Coagulation Disorders; Citrulline; Cyclic GMP; Humans; Lysine; Male; Nitric Oxide; Nitroglycerin; Ornithine; Peptide Hydrolases; Platelet Aggregation; Thrombosis	1999
[Disorders of hemostasis in malignant neoplasms]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1977, Sep-01, Volume: 30, Issue:17 Topics: Arginine; Blood Coagulation Disorders; Fibrin; Humans; Neoplasm Metastasis; Neoplasms; Thrombosis	1977
Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1991, Volume: 2, Issue:4 Topics: Amino Acids; Arginine; Blood Coagulation Disorders; Chromatography, High Pressure Liquid; Coagulase; Fibrinogens, Abnormal; Fibrinopeptide A; Histidine; Humans; Macromolecular Substances; Male; Middle Aged; Pedigree; Thrombin Time	1991
[Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Schweizerische medizinische Wochenschrift, 1991, Jul-20, Volume: 121, Issue:29 Topics: Adult; Arginine; Blood Coagulation Disorders; Cysteine; Female; Fibrinogens, Abnormal; Fibrinopeptide A; Humans; Middle Aged; Pedigree; Prothrombin Time; Thrombin	1991
Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization. Blood, 1991, Oct-01, Volume: 78, Issue:7 Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Calcium; Child; Chromatography, High Pressure Liquid; Cysteine; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Macromolecular Substances; Male; Molecular Sequence Data; Platelet Aggregation	1991
Molecular defects of factor IX Chicago-2 (Arg 145----His) and prothrombin Madrid (Arg 271----cys): arginine mutations that preclude zymogen activation. Blood, 1989, Volume: 74, Issue:1 Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Chromatography, High Pressure Liquid; Enzyme Activation; Factor IX; Humans; Molecular Sequence Data; Molecular Weight; Mutation; Peptide Mapping; Prothrombin; Structure-Activity Relationship	1989
Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site. The Journal of biological chemistry, 1988, Sep-25, Volume: 263, Issue:27 Topics: Adolescent; Aged; Amino Acid Sequence; Amino Acids; Arginine; Blood Coagulation Disorders; Calcium; Chromatography, High Pressure Liquid; Cysteine; Cystine; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Humans; Male; Molecular Sequence Data; Mutation; Peptide Fragments; Serine Endopeptidases; Thrombin Time	1988
Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia. Thrombosis and haemostasis, 1986, Dec-15, Volume: 56, Issue:3 Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Child, Preschool; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Genetic Variation; Histidine; Humans; Middle Aged; Protein Conformation	1986
Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains. Journal of biochemistry, 1987, Volume: 102, Issue:1 Topics: Amino Acid Sequence; Arginine; Blood Coagulation Disorders; Cysteine; Disulfides; Fibrinogen; Fibrinogens, Abnormal; Humans; Macromolecular Substances; Molecular Sequence Data; Molecular Weight	1987
Prothrombin Clamart: prothrombin variant with defective Arg 320-IIe cleavage by factor Xa. Thrombosis research, 1986, Oct-01, Volume: 44, Issue:1 Topics: Adult; Arginine; Blood Coagulation Disorders; Factor X; Factor Xa; Female; Genetic Variation; Heterozygote; Humans; Immunoelectrophoresis, Two-Dimensional; Prothrombin; Prothrombin Time; Structure-Activity Relationship; Thrombin	1986
On the physiological role of 2 -macroglobulin. Biochimica et biophysica acta, 1973, Jan-25, Volume: 295, Issue:1 Topics: Angiotensin II; Arginine; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Proteins; Caseins; Chromatography, Gel; Chymotrypsinogen; Enzyme Activation; Esters; Fibrin; Fibrinogen; Hemoglobins; Humans; Hydrolysis; Macroglobulins; Pancreatitis; Protein Binding; Protein Denaturation; Thrombin; Trypsin; Trypsin Inhibitors; Trypsinogen; Vasopressins	1973
Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity. Circulation research, 1974, Volume: 34, Issue:5 Topics: Aprotinin; Arginine; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Bradykinin; Citrates; Esterases; Factor XI; Factor XII; Humans; In Vitro Techniques; Kallikreins; Kaolin; Kininogens; Kinins; Trypsin	1974
Proteolytic activity of serum bound with alpha 2-macroglobulin in diseases with reduced thrombin formation in clotting blood. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 31, Issue:1 Topics: Acenocoumarol; Adolescent; Adult; Aged; Amides; Arginine; Blood Coagulation; Blood Coagulation Disorders; Humans	1971